A multicenter phase II study in adults with untreated acute lymphoblastic leukemia: testing pharmacokinetically individualized doses of L-asparaginase following the DFCI Pediatric Consortium protocol.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 12 Feb 2018
At a glance
- Drugs Asparaginase (Primary) ; Cytarabine; Dexamethasone; Doxorubicin; Folinic acid; Folinic acid; Hydrocortisone; Mercaptopurine; Methotrexate; Methotrexate; Prednisone; Vincristine
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 08 Feb 2018 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 08 Feb 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.